Results 191 to 200 of about 236,444 (370)
Brain‐derived neurotrophic factor and nerve growth factor potentiate excitatory synaptic transmission in the rat visual cortex. [PDF]
Giorgio Carmignoto+3 more
openalex +1 more source
Research advances in dysphagia animal models
This review systematically summarizes the establishment, evaluation, and detection of dysphagia animal models in stroke, Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) in three kinds of experimental animals (including rodents, nonhuman primates, and other mammals), providing a basis for the selection of appropriate animal models of ...
Junhui Bai+5 more
wiley +1 more source
Plasma Brain-derived Neurotrophic Factor in Hemodialysis Patients
Objective: Brain-derived neurotrophic factor (BDNF) is a neurotrophin which modulates neuronal survival and proliferation. Recently, plasma BDNF is associated with inflammatory conditions.
Seok Joon Shin, Hye Eun Yoon, Sungjin Chung, Yong Gu Kim, Dai-Jin Kim
doaj
Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain [PDF]
Yasuhiro Kawamoto+5 more
openalex +1 more source
Amantadine (AMA) regulates neurocyte apoptosis and inhibits neurocyte inflammation to prevent maternal immune activation (MIA) from affecting offspring behavior. Abstract Background Maternal viral infection during pregnancy can lead to maternal immune activation (MIA), increasing the risk of neurodevelopmental disorders in offspring.
Jianfei Wu+8 more
wiley +1 more source
Expression of Specific Tubulin Isotypes Increases during Regeneration of Injured CNS Neurons, But Not after the Application of Brain-Derived Neurotrophic Factor (BDNF) [PDF]
Alyson E. Fournier, Lisa McKerracher
openalex +1 more source
Post‐stroke depression (PSD) animal model of traditional Chinese medicine (TCM) combined with disease and syndrome often uses western medicine surgery (including: middle cerebral artery embolization to construct cerebral ischemia, or brain injection of collagenase to construct cerebral hemorrhage) combined with other methods (including: isolation ...
Jielin Wang+4 more
wiley +1 more source
Objective Tofersen is the first effective and approved therapy for superoxide dismutase 1 (SOD1)‐associated amyotrophic lateral sclerosis (ALS [SOD1‐ALS]). Following treatment with tofersen, neurofilament levels in patients' cerebrospinal fluid (CSF) and serum seem to respond earlier than clinical parameters.
Christina Steffke+36 more
wiley +1 more source